Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Aequs and Tramontina announce joint venture to manufacture cookware products in India The facilities at the Hubballi Durable Goods Cluster will manufacture products for customers in India and abroad - Trentar Energy Solutions to commercialise KPITs’ breakthrough Sodium Ion Battery Technology - "GULZAR" 8th Solo Show of Paintings will be displayed by renowned artist Virendra Chopde at Kismat Art Gallery in Mumbai - Finkurve Financial Services Limited appoints Mr. CVR. Rajendran as an Strategic Advisor - QUALITY POWER ELECTRICAL EQUIPMENTS LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING OPENS (IPO) ON FRIDAY, FEBRUARY 14, 2025 Sets Price band fixed at ₹ 401 to ₹425 per Equity Share of face value of ₹10 each - “Urban Whispers” An Exhibition of Paintings will be displayed by renowned artist Ajit Deswandikar at Jehangir Art Gallery in Mumbai - ARTIVAL FOUNDATION Presents "ART CONTINUUM" An Exhibition of Paintings & Sculptures will displayed at Nehru Centre Art Gallery in Mumbai - Cancer Survivors Meet 2025 Celebrates Strength, Hope, and Resilience at HCG ICS Khubchandani Cancer Centre - Kalyan Jewellers Launches ‘Crafting Futures’ Initiative to Uplift Artisans This initiative is dedicated to improving the livelihoods of jewellery artisans - Hexaware Technologies Limited Announced its Initial public offering (IPO) to open on Wednesday, February 12, 2025 Sets Price Band fixed at ₹ 674 per equity share to ₹ 708 per equity share of the face value of ₹1 each

Suraksha Diagnostic Limited files DRHP with SEBI

Suraksha Diagnostic Limited files DRHP with SEBI

Mumbai, 30th July 2024 (GNI): Suraksha Diagnostic Limited, the largest full-service and integrated diagnostic chain headquartered in east India, in terms of operating income as of Fiscal 2023 as per a CRISIL Report, has filed the draft red herring prospectus (DRHP) with capital markets regulator SEBI to float an initial public offering (IPO).

According to thedraft red herring prospectus, the Initial Public Offering of the Kolkata headquartered company consists of an Offer for Sale of up to 19,189,330 Equity Shares by the Selling Shareholders.

The OFS comprises of up to 10,660,737 Equity Shares by the Investor Selling Shareholder – OrbiMed Asia II Mauritius Limited; up to2,132,148 Equity Shares each by the Promoter Selling Shareholders – Dr. Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma, and the Individual Selling Shareholders, Munna Lal Kejriwal and Santosh Kumar Kejriwal offering up to 799,556 Equity Shares and up to 1,332,593 Equity Shares, respectively.

The objects of the Offer are to carry out the Offer for Sale of up to 19,189,330 Equity Shares by the Selling Shareholders; and achieve the benefits of listing the Equity Shares on the Stock Exchanges

Dr. Somnath Chatterjee along with late Kishan Kumar Kejriwal built a fully comprehensive diagnostic centre in Kolkata, under the ‘Suraksha’ brand in 1992. The company which is currently promoted by Dr. Somnath Chatterjee, Joint Managing Director, and Ritu Mittal, Joint Managing Director and Chief Executive Officer offers a one-stop integrated solution for pathology and radiology testing, and medical consultation services to its customers through its extensive operational network, consisting of a flagship central reference laboratory, 8 satellite laboratories (co-located with diagnostic centers) and 194 customer touchpoints which include 48 diagnostic centres, and 146 sample collection centres (primarily franchised), across the states of West Bengal, Bihar, Assam, and Meghalaya, as of March 31, 2024.

Suraksha offers a comprehensive range of 2,300+ tests that cover a range of specialties and disciplines. During Fiscal 2024, it conducted approximately 5.98 million tests serving approximately 1.14 million patients.

ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited are the book running lead managers to the issue. The equity shares are proposed to be listed on BSE and NSE.

Link to DRHP:

https://www.icicisecurities.com/Upload/ArticleAttachments/Suraksha%20Diagnostic%20Limited%20-%20Draft%20Red%20Herring%20Prospectus.pdf

Be the first to comment on "Suraksha Diagnostic Limited files DRHP with SEBI"

Leave a comment

Your email address will not be published.


*